Allez Health Raises $60M in Funding for CGM Biosensor Platform's Production, Compliance, and Marketing

Allez Health's Series A+ Financing

Key Highlights:

• Series A+ Financing: Raised $60 million in a Series A+ financing round led by Osang Healthcare Co.
• CGM Biosensor Platform: Provides a continuous glucose monitoring (CGM) biosensor platform with sensor technology to enhance performance and user experience.
• Milestones: Accomplished several milestones, including issued patents, pending patent applications, clinical studies, and a pivotal study in insulin users.

Allez Health's Target Market

• Target Market: Individuals with diabetes or those who require continuous glucose monitoring.
• Healthcare Providers and Specialists: Endocrinologists, diabetologists, and other healthcare professionals specializing in diabetes management.
• Medical Device Distributors: Companies specializing in distributing medical devices and technologies to healthcare providers and institutions.

What Allez Health Needs to Buy

• Manufacturing and Supply Chain Solutions: Collaborating with manufacturers for the production of their CGM biosensor platform and managing a reliable supply chain.
• Regulatory Compliance Services: Partnering with regulatory experts to navigate the approval process and ensure compliance with relevant authorities.
• Marketing and Sales Expertise: Engaging with marketing agencies and sales experts to effectively reach their target market and healthcare providers.